ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,018.39
-0.34%
Dow Jones
37,903.29
0.00%
US Dollar vs MXN
16.95526
0.07%
Brent Oil
84.23
0.83%
Bitcoin
58,457.71
0.38%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
02/05/202407:02Business WireMedallia Recognized as a Leader in SPARK Matrix™ Digital Marketing Analytics Report Q4 2023
02/05/202407:01Business WireInsight Enterprises, Inc. Reports Record First Quarter ResultsNASDAQ:NSITInsight Enterprises Inc
02/05/202407:01Business WireFeedzai Bolsters C-suite With New Chief Financial Officer
02/05/202407:01Business WireFiscalNote to Report First Quarter 2024 Financial Results on May 9NYSE:NOTEFiscaNote Holdings Inc
02/05/202407:01Business WireCFO of Insight, Glynis Bryan, Announces RetirementNASDAQ:NSITInsight Enterprises Inc
02/05/202407:00Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNYSE:CHAACatcha Investment Corp
02/05/202407:00Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
02/05/202407:00InvestorsHub NewsWireAvant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration FirmUSOTC:AVAIAvant Technologies Inc (QB)
02/05/202407:00GlobeNewswire Inc.Lisata Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update on Thursday, May 9, 2024NASDAQ:LSTALisata Therapeutics Inc
02/05/202407:00GlobeNewswire Inc.Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical TrialNASDAQ:SNCEScience 37 Holdings Inc
02/05/202407:00GlobeNewswire Inc.Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian CancerNASDAQ:ALLRAllarity Therapeutics Inc
02/05/202407:00Business WireWNS to Participate at Q2’24 Investor ConferencesNYSE:WNSWNS Holdings Limited
02/05/202407:00GlobeNewswire Inc.Data and AI Consultancy Indicium Scales with $40 Million Investment from Columbia Capital
02/05/202407:00Business WireNew Study Published in JACC: Heart Failure Reveals that Despite Significant Efforts to Improve Acute Heart Failure Treatment Over the Past 20 Years, Management Remains Unchanged
02/05/202407:00GlobeNewswire Inc.iCAD to Report First Quarter 2024 Financial Results on May 15, 2024NASDAQ:ICADIcad Inc
02/05/202407:00Business WireCharles River Launches Viral Vector Reference Materials to Streamline the Transition to GMPNYSE:CRLCharles River Laboratories International Inc
02/05/202407:00Business WireCrowdStrike and Tata Consultancy Services (TCS) Announce Global Strategic Partnership to Transform Modern Enterprise CybersecurityNASDAQ:CRWDCrowdStrike Holdings Inc
02/05/202407:00Business WireVersa Networks Adds AI-Powered Security Capabilities to its Unified SASE Platform
02/05/202407:00GlobeNewswire Inc.The Canadian Dermatology Association (CDA) Announces the Launch of the 2024 Shade Structure Grant Program
02/05/202407:00GlobeNewswire Inc.NewAmsterdam Pharma to Host R&D Day with Key Opinion Leaders on May 16, 2024NASDAQ:NAMSNewAmsterdam Pharma Company NV
02/05/202407:00GlobeNewswire Inc.Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical WorkflowsNASDAQ:AKYAAkoya BioSciences Inc
02/05/202407:00Business WireWestern Asset Inflation-Linked Opportunities & Income Fund (NYSE: WIW) Announces Portfolio Management Team UpdateNYSE:WIWWestern Asset Inflation Linked Opportunities & Income Fund
02/05/202407:00Business WireJoby Progresses to Next Phase of Aircraft Flight Test ProgramNYSE:JOBYJoby Aviation Inc
02/05/202407:00GlobeNewswire Inc.LifeMD Becomes the First Virtual Primary Care Provider to Elevate GLP-1 Patient Care with Real-time, At-Home Monitoring of Blood Pressure and Body CompositionNASDAQ:LFMDLifeMD Inc
02/05/202407:00GlobeNewswire Inc.XpresSpa Introduces IV Hydration Drip Therapy at Miami International AirportNASDAQ:XWELXWELL Inc
02/05/202407:00GlobeNewswire Inc.Alterra IOS Venture III raises $925 million, surpassing $750 million target and increasing hard cap beyond $850 million
02/05/202407:00GlobeNewswire Inc.FOREWARN Partners with Virginia REALTORS®NASDAQ:RDVTRed Violet Inc
02/05/202407:00Business WireSolarWinds Announces First Quarter 2024 ResultsNYSE:SWISolarWinds Corporation
02/05/202407:00Business WireENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International PatentsNASDAQ:NDRAENDRA Life Sciences Inc
02/05/202407:00GlobeNewswire Inc.Optimizing Application Connections and Improving Security Posture Among Top SD-WAN Deployment Drivers

Su Consulta Reciente

NASDAQ
GOOGL
Alphabet
CCOM
OILBRENT
Brent Oil
CCOM
SILVER
SILVER
CCOM
US500
US 500
NASDAQ
TSLA
Tesla
PM
XAUUSD
Gold vs US Dollar
USI
USTECH100
US Tech 100
SPI
SP500
S&P 500
COIN
ETHUSD
Ethereum
NYSE
KO
Coca Cola
AMEX
XLE
Energy Select Sector SPDR
NYSE
JPM
JP Morgan Chase
USOTC
BASFY
BASF (QX)
NYSE
VZ
Verizon Communications
USOTC
RHHBY
Roche (QX)
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados